CID 16204636

5'-gagtgggca-3'

Structural Information

Molecular Formula
C89H111N40O45P9S9
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5CC(OC5COP(=S)(O)O)N6C=NC7=C6N=C(NC7=O)N)N8C=NC9=C(N=CN=C98)N)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)O)S
InChI
InChI=1S/C89H111N40O45P9S9/c1-32-13-122(89(138)120-77(32)131)54-6-35(45(160-54)17-152-180(145,189)172-39-10-58(127-29-106-65-74(127)112-85(95)117-80(65)134)164-48(39)20-155-181(146,190)170-37-7-55(124-26-103-62-69(92)99-24-101-71(62)124)162-46(37)18-153-178(143,187)169-36-8-56(161-43(36)15-149-175(139,140)184)125-27-104-63-72(125)110-83(93)115-78(63)132)168-177(142,186)154-19-47-40(11-59(163-47)128-30-107-66-75(128)113-86(96)118-81(66)135)173-182(147,191)157-22-50-41(12-60(166-50)129-31-108-67-76(129)114-87(97)119-82(67)136)174-183(148,192)156-21-49-38(9-57(165-49)126-28-105-64-73(126)111-84(94)116-79(64)133)171-179(144,188)151-16-44-34(5-53(159-44)121-3-2-51(90)109-88(121)137)167-176(141,185)150-14-42-33(130)4-52(158-42)123-25-102-61-68(91)98-23-100-70(61)123/h2-3,13,23-31,33-50,52-60,130H,4-12,14-22H2,1H3,(H,141,185)(H,142,186)(H,143,187)(H,144,188)(H,145,189)(H,146,190)(H,147,191)(H,148,192)(H2,90,109,137)(H2,91,98,100)(H2,92,99,101)(H,120,131,138)(H2,139,140,184)(H3,93,110,115,132)(H3,94,111,116,133)(H3,95,112,117,134)(H3,96,113,118,135)(H3,97,114,119,136)
InChIKey
MVBKXYDEVCVHGL-UHFFFAOYSA-N
Compound name
1-[4-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(4-amino-2-oxopyrimidin-1-yl)-3-[[5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-sulfanylphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-(dihydroxyphosphinothioyloxymethyl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(6-aminopurin-9-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-2-yl]-5-methylpyrimidine-2,4-dione
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

3026.2751 Da
Monoisotopic Mass

-5.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 3027.2824 294.3
[M+Na]+ 3049.2643 297.7
[M-H]- 3025.2678 294.4
[M+NH4]+ 3044.3089 295.5
[M+K]+ 3065.2383 296.1
[M+H-H2O]+ 3009.2724 294.8
[M+HCOO]- 3071.2733 295.8
[M+CH3COO]- 3085.2890 296.1
[M+Na-2H]- 3047.2498 298.3
[M]+ 3026.2746 297.8
[M]- 3026.2756 297.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.